New Life-Saving Malaria Vaccine in the Works

Oct 29, 2013

London Evening Standard

Development for a new, heat-resistant malaria vaccine has begun. A partnership beteen GlaxoSmithKline adnd the Bill and Melinda Gates Foundation worth $1.8 million is aimed at developing a malaria drug that does not require refrigeration.

There are roughly 660,000 malaria deaths a year--many victims are children in Sub-Saharan Africa where many are without access to vaccinations. A major issue in these areas is the heat, as many drugs are not heat-stable. Companies are now striving to break the "cold chain" to provide necessary vaccines across the world.

Read the full story.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments